Gonadoliberin derivatives containing a .beta.-aspartyl group, a

Details Gonadoliberin derivatives containing a .beta.-aspartyl group, a Gonadoliberin derivatives containing a .beta.-aspartyl group, a

1984-03-29

1986-07-15

Phillips, Delbert R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

2601125R, 2601125LH, A61K 3702, C07C10352

Patent

active

046007059

ABSTRACT:
The invention relates to novel gonadoliberine derivatives of the general formula (I) ##STR1## wherein X represents an --O--R group wherein R is a benzyl group or a C.sub.1-4 alkyl group, an ##STR2## group wherein R1 and R2 independently stand for hydrogen, a C.sub.1-5 alkyl, aryl, aryl-C.sub.1-2 -alkyl, morpholino, 1-indolinyl or 1-pyrrolidinyl group,

REFERENCES:
patent: 4118483 (1978-10-01), Konig et al.
patent: 4395400 (1983-07-01), Konig et al.
Chemical Abstracts, vol. 100, 1984, Abst. No. 156992u.
Chemical Abstracts, vol. 101, 1984, Abst. No. 204336c.

Affiliated with

Also associated with

Rating

Gonadoliberin derivatives containing a .beta.-aspartyl group, a does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gonadoliberin derivatives containing a .beta.-aspartyl group, a , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gonadoliberin derivatives containing a .beta.-aspartyl group, a will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1741227